Search - tctmd.com

Displaying 21 - 33 of 33

Sort: Relevancy | Date

Presentation THT 2025

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT 2025

Putting It All Together: A Case of TTVR

Presenter: Karl-Philipp Rommel

February 12, 2025

Presentation THT 2025

TTVI Trial Updates

Presenter: Rebecca Hahn

February 12, 2025

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Conference News THT 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Caitlin E. Cox

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

Presentation THT 2022

Implications of RVF in Structural Heart Procedures

Presenter: Rebecca Hahn

February 02, 2022

Presentation THT 2022

Development of a Hybrid Trainer For Improving Fluoroscopy-Only Interventions in Structural Heart Disease and Heart Failure Using Real-Time Electromagnetic Tracking in Mixed Reality

Presenter: Sun-Joo Jang

February 01, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Advertisement

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Putting It All Together: A Case of TTVR

TTVI Trial Updates

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Debating the Role of T-TEER in the Sickest Patients

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Implications of RVF in Structural Heart Procedures

Development of a Hybrid Trainer For Improving Fluoroscopy-Only Interventions in Structural Heart Disease and Heart Failure Using Real-Time Electromagnetic Tracking in Mixed Reality

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content